Myriad Genetics Introduces Online Prenatal Genetic Testing Resource
SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, has launched a new educational website providing ...
Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced a study revealing that more patients completed hereditary cancer testing when they used an online ...
Seeking Alpha6d
Myriad Genetics: Navigating Through A Setback
MyRisk Hereditary Cancer Test: This is a DNA sequencing test for assessing the risks for hereditary cancers. Myriad Genetics posted ... due to a decline in legal costs compared to 3Q2023.
Medindia1d
Prostate Cancer: Are Genomic Tests the Future of Risk Assessment?
A systematic review highlights the potential of genomic tests in prostate cancer treatment decisions but calls for more data ...
Nasdaq6d
Demystifying Myriad Genetics: Insights From 6 Analyst Reviews
Myriad Genetics is a molecular diagnostics company that provides testing services designed to ... showcases strong profitability and effective cost control. Return on Equity (ROE): Myriad ...
News Medical on MSN2d
Exploring the use of genomic classifier tests in prostate cancer risk stratification
A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...
EurekAlert!2d
Gene classifier tests for prostate cancer may influence treatment decisions despite lack of evidence for long-term outcomes
A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...
Le Lézard2d
Diversity Supplier Myriad Medical Supply Strengthens Leadership and Portfolio Ahead of Expected Supply Challenges
Myriad Medical Supply today announced that the company has upgraded its portfolio of disposable medical products and hired David Nichols, a veteran leader in the healthcare industry, to serve ...
Global Gastric Cancer Diagnostics Market Is Anticipated To Grow At A CAGR Of ~7% By 2030, Estimates Delveinsight
Gastric cancer diagnostics companies are Abbott, BD, Bio-Rad Laboratories, Roche, Siemens Healthineers, Thermo Fisher Scientific, Pillar Biosciences, ETC ...
BlackDoctor2d
How Clinical Trials Can Find a Cure for Relapsed DLBCL
This article will explore what DLBCL is and how clinical trials can potentially lead to breakthroughs in treatment.
So many young people with colon cancer have clean diets. What gives?
The rising rate of colon cancer in young people can't be caused by diet alone, doctors say. Microplastics, sleep, and antibiotics may play a role.
manilatimes3d
Mitolyn Introduces a 6-Second Purple Peel Discovery-Mitolyn Sets a New Standard for Rapid Weight Management
In the following sections, this press release dives into the science behind Mitolyn, shares real-world success stories, and ...